Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Somatic mutations in acute myeloid leukemia are acquired sequentially and hierarchically. First, pre-leukemic mutations, such as t(8;21) that encodes AML1-ETO, are acquired within the hematopoietic stem cell (HSC) compartment, while signaling pathway mutations, including KRAS activating mutations, are late events acquired during transformation of leukemic progenitor cells and are rarely detectable in HSC. This raises the possibility that signaling pathway mutations are detrimental to clonal expansion of pre-leukemic HSC. To address this hypothesis, we used conditional genetics to introduce Aml1-ETO and K-RasG12D into murine HSC, either individually or in combination. In the absence of activated Ras, Aml1-ETO-expressing HSC conferred a competitive advantage. However, activated K-Ras had a marked detrimental effect on Aml1-ETO-expressing HSC, leading to loss of both phenotypic and functional HSC. Cell cycle analysis revealed a loss of quiescence in HSC co-expressing Aml1-ETO and K-RasG12D, accompanied by an enrichment in E2F and Myc target gene expression and depletion of HSC self-renewal-associated gene expression. These findings provide a mechanistic basis for the observed absence of KRAS signaling mutations in the pre-malignant HSC compartment.

Original publication

DOI

10.3324/haematol.2018.205351

Type

Journal article

Journal

Haematologica

Publication Date

11/2019

Volume

104

Pages

2215 - 2224

Keywords

Animals, Cell Proliferation, Cell Transformation, Neoplastic, Core Binding Factor Alpha 2 Subunit, Gene Expression, Gene Expression Profiling, Hematopoietic Stem Cells, Humans, Mice, Mice, Transgenic, Models, Animal, Models, Biological, Mutation, Oncogene Proteins, Fusion, Precancerous Conditions, Proto-Oncogene Proteins p21(ras), RUNX1 Translocation Partner 1 Protein